Giovanni C.
- Country
- France
- Department
- 6805: Neurology
Research Overview
- A DOSE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF UCB0599 IN STUDY PARTICIPANTS WITH PARKINSON’S DISEASE
- Botulinum toxin type A for refractory upper‑limb resting tremor in Parkinson’s disease: a double‑blind, placebo‑controlled crossover trial
- Evaluation of Ocrelizumab Efficacy and Safety in Multiple Sclerosis Patients from a Prior Phase IIIb/IV Trial
Data & Insights
Has run more than one trial at 170 of 390 partner sites.
Specializations
Neurodegenerative Disorders
The investigator specializes in treating various forms of Parkinson's disease, including advanced stages and GBA1 gene variants. Their work encompasses evaluation of novel therapeutic approaches for motor fluctuations and disease progression.
- Advanced Parkinson's Disease Management
- Motor Fluctuation Treatment
- GBA-PD Therapeutic Approaches
Multiple Sclerosis
Focused on both relapsing and progressive forms of multiple sclerosis, with particular attention to primary progressive MS and secondary progressive MS. The investigator evaluates long-term therapeutic solutions and disease modification strategies.
- Progressive MS Treatment
- Relapsing MS Management
- Long-term Disease Modification
Rare Neurological Conditions
Expertise in treating Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy, with additional focus on Neurogenic Orthostatic Hypotension and episodic migraine management.
- PSP Disease Progression
- Autonomic Dysfunction
- Migraine Prevention
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.